FDA inspection
Takashi Kamezawa: FDA inspection ending Dec 5, 2025
FDA inspection 1294738 · Voluntary Action Indicated (VAI) · Kasugai
Key facts
| Inspection ID | 1294738 |
|---|---|
| Firm | Takashi Kamezawa |
| FEI number | 3039694939 |
| Address | 10 Chome 12-2, Higashino-Cho |
| City | Kasugai |
| Country | Japan |
| Fiscal year | 2026 |
| Inspection end date | Dec 5, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data